BETTUZZI, Saverio
 Distribuzione geografica
Continente #
NA - Nord America 8.910
AS - Asia 8.318
EU - Europa 5.388
SA - Sud America 1.223
AF - Africa 392
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 15
Totale 24.263
Nazione #
US - Stati Uniti d'America 8.641
SG - Singapore 2.931
CN - Cina 2.282
VN - Vietnam 1.489
IE - Irlanda 966
BR - Brasile 931
UA - Ucraina 754
IT - Italia 710
FI - Finlandia 660
SE - Svezia 644
HK - Hong Kong 571
DE - Germania 547
FR - Francia 307
ZA - Sudafrica 262
NL - Olanda 251
BD - Bangladesh 240
CA - Canada 204
TR - Turchia 165
AT - Austria 138
GB - Regno Unito 135
IN - India 121
AR - Argentina 114
RU - Federazione Russa 101
KR - Corea 85
IR - Iran 70
IQ - Iraq 57
EC - Ecuador 53
JP - Giappone 42
PH - Filippine 39
BE - Belgio 38
ID - Indonesia 35
MX - Messico 35
CI - Costa d'Avorio 33
VE - Venezuela 33
CO - Colombia 32
UZ - Uzbekistan 28
PL - Polonia 27
TH - Thailandia 22
MA - Marocco 21
ES - Italia 20
PK - Pakistan 19
CZ - Repubblica Ceca 18
EG - Egitto 18
SA - Arabia Saudita 18
PY - Paraguay 17
CL - Cile 14
TW - Taiwan 14
AU - Australia 13
KE - Kenya 13
EU - Europa 12
PE - Perù 12
SK - Slovacchia (Repubblica Slovacca) 12
TN - Tunisia 12
UY - Uruguay 12
AE - Emirati Arabi Uniti 11
LT - Lituania 11
IL - Israele 10
NP - Nepal 10
AZ - Azerbaigian 9
DZ - Algeria 7
JO - Giordania 7
RO - Romania 7
DO - Repubblica Dominicana 6
ET - Etiopia 6
KG - Kirghizistan 6
BG - Bulgaria 5
BO - Bolivia 5
CH - Svizzera 5
CR - Costa Rica 5
KZ - Kazakistan 5
OM - Oman 5
AL - Albania 4
AM - Armenia 4
HN - Honduras 4
LB - Libano 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
SN - Senegal 4
TT - Trinidad e Tobago 4
DK - Danimarca 3
GE - Georgia 3
HU - Ungheria 3
JM - Giamaica 3
KW - Kuwait 3
LU - Lussemburgo 3
LV - Lettonia 3
NG - Nigeria 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
BI - Burundi 2
BY - Bielorussia 2
EE - Estonia 2
GA - Gabon 2
HR - Croazia 2
LA - Repubblica Popolare Democratica del Laos 2
MR - Mauritania 2
NI - Nicaragua 2
SI - Slovenia 2
Totale 24.245
Città #
Singapore 1.273
Dublin 963
Ashburn 941
Jacksonville 868
Chandler 833
San Jose 702
Hong Kong 538
Dearborn 509
Santa Clara 508
Beijing 479
Ho Chi Minh City 431
Hanoi 325
Boardman 281
Nanjing 272
Dallas 259
Ann Arbor 248
Johannesburg 242
San Mateo 224
Princeton 211
Lauterbourg 176
Parma 170
Los Angeles 156
Toronto 142
Shanghai 127
Vienna 124
Wilmington 117
Hefei 113
Izmir 113
New York 102
Nanchang 96
Shenyang 96
São Paulo 86
Jinan 81
Munich 81
Helsinki 79
Hebei 73
Moscow 68
Leawood 67
Des Moines 65
Da Nang 62
Haiphong 62
Kunming 61
Seoul 61
Tianjin 59
Changsha 56
Buffalo 53
Guangzhou 52
Jiaxing 49
Council Bluffs 43
Columbus 42
Marseille 41
Houston 38
Milan 38
Augusta 37
Brussels 37
Turku 36
Seattle 35
Abidjan 33
Rome 32
Tokyo 32
Brooklyn 31
Chicago 31
Fremont 31
The Dalles 31
Ardabil 30
Haikou 30
Biên Hòa 29
Rio de Janeiro 29
Woodbridge 29
London 28
Tashkent 25
Zhengzhou 25
Hải Dương 24
Nuremberg 24
Frankfurt am Main 23
Kocaeli 23
Orem 23
Warsaw 22
Atlanta 21
Norwalk 21
Ardea 20
Montreal 20
Mumbai 20
Ninh Bình 20
Quito 20
Baghdad 19
Belo Horizonte 19
Hangzhou 19
Monmouth Junction 19
Bologna 18
Curitiba 18
Denver 18
Stockholm 18
Amsterdam 17
Chengdu 17
Modena 16
Phoenix 16
Porto Alegre 16
Redondo Beach 16
Taiyuan 16
Totale 14.090
Nome #
Demethylation of (Cytosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development 474
Effects of standardized green tea extract and its main component, EGCG, on mitochondrial function and contractile performance of healthy rat cardiomyocytes 299
Flavonoids as epigenetic modulators for prostate cancer prevention 246
Long-Term Oral Administration of Theaphenon-E Improves Cardiomyocyte Mechanics and Calcium Dynamics by Affecting Phospholamban Phosphorylation and ATP Production 238
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 232
Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF-κB-Dependent Mechanism 230
ATTIVITÀ CHEMIO PREVENTIVA DELLE CATECHINE DEL TÈ VERDE NEL CANCRO DELLA PROSTATA 213
The Potential of Epigallocatechin Gallate (EGCG) in Targeting Autophagy for Cancer Treatment: A Narrative Review 211
Clusterin 204
The down-regulation of clusterin expression enhances the αsynuclein aggregation process 198
Acute hyperbaric oxygen (HBO) treatment rapidly upregulate ODC and downregulate SSAT in the rat heart, boosting polyamine tissue concentration: evidence for a protective role of natural polyamines in heart failure as naturally occurring in vivo antioxidants? 194
AA Sequencing, Glycosylation and Phosphorylation Site Characterization of Human Serum Clusterin using Liquid Chromatography-High Resolution Mass Spectrometry 192
A novel transgenic model for prostate cancer displays the tumor-suppressor activity of Clusterin 192
CLU expression negatively modulates prostate cancer progression by inhibiting NF-kB activity 191
Lemur tyrosine kinases and prostate cancer: A literature review 188
Molecular targets of epigallocatechin—gallate (EGCG): A special focus on signal transduction and cancer 187
Epigenetic regulation of clusterin transcriptional variants in normal, immortalized and cancerous human cell lines 184
Rat cardiac polyamine metabolism response to HBO (hyperbaric oxygen)depends on intensity of treatment 181
Chronic administration of green tea extract to TRAMP mice induces the collapse ofGolgi apparatus in prostate secretory cells and results in alterations of proteinpost-translational processing. 177
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 175
Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells 173
Apoptosi: ruolo fisiologico della morte cellulare 169
Age-dependent expression of sulphated glycoprotein-2 (SGP-2) transcript in the ventral prostate of rats 169
Changes in rat SOD activity localization following HBO treatment 168
Upregulation of Clusterin in Prostate and DNA Damage in Spermatozoa from Bisphenol A-Treated Rats, and Formation of DNA Adducts in Cultured Human Prostatic Cells 168
Changes in prostate polyamine metabolism by green tea catechins in autochtonous mouse model of prostate cancer (TRAMP mice) 166
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 166
Polyphenon E®, a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis 165
The role of clusterin on alpha-synuclein aggregation in an “in vitro” model of Parkinson disease 165
CLUSTERIN IS EPIGENETICALLY REPRESSED IN HUMAN PROSTATE CANCER CELLS 162
Protezione del miocardio ischemico: protezione del miocardio mediante attivita' fisica ed ossigeno iperbarico; valutazione dello stress metabolico, del quadro ossidativo e ormonale 162
MOLECULAR MECHANISM OF ACTION OF POLYPHENON E, A GREEN TEA EXTRACT, IN BENIGN AND TUMORIGENIC PROSTATE EPITHELIAL CELLS 160
Chemoprevention of human prostate cancer by oral administration of green tea catechins (GTCs) in high grade PIN subjects: a preliminary report from a 1 year proof of principle study 159
Effects of CLU over-expression on NF-kB target genes involved in invasion mechanims: preliminary results 159
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR. 159
Green tea catechins for prostate cancer prevention: Present achievements and future challenges 159
Effects of Clusterin knock down on prostate cancer progression in the tramp model 157
Chemoprevention of Human Prostate Cancer by Oral Administration of Green Tea Catechins (GTCs) in High Grade PIN Volunteers: a Preliminary Report from a 1 Year Proof-of-Principle Study 154
Chronic Administration of Green Tea Extracts in TRAMP Mice Reduces the Activity of the Secretory Pathway Causing an Imbalance of the Protein Trafficking 151
Chemoprevention of human prostate cancer by green tea catechins: two years later, a follow-up update 150
A New transgenic model for prostate cancer and the role of CLU in tumorigenesis 150
Anticancer activity of green tea polyphenols in prostate gland 150
Roles of Autophagy Induced by Natural Compounds in Prostate Cancer 150
B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: Implications for cell survival 150
Clusterin is epigenetically repressed in human prostate cancer cells 149
Chemoprevention of human prostate cancer (PCa) by oral administration of green tea catechins (GTCs) in high grade pin (HGPIN) subjects: a preliminary report from a 1 year proof of principle study 148
Molecular targets of (-)-Epigallocatechin-3-gallate (EGCG): Specificity and interaction with membrane lipid rafts 148
Deciphering the role of the molecular chaperone clusterin on α-synuclein aggregation. 146
EGCG antagonizes Bortezomib-, but not MG132-induced cell death in prostate cancer cells 145
Clusterin as possible biomarker of response to treatment of prostate cancer cells with Polyphenon E 145
Clusterin (CLU): From one gene and two transcripts to many proteins 144
Aspects of protein biosynthesis in hypertrophic growth of rat heart 143
Clinical relevance of green tea catechins on prostate cancer progression in “high risk” men in combination with molecular profiling of catechin-resistant tumors” 143
Anti-tumor activity of Green Tea Catechins against human prostate cancer: the clinical trial 142
Chemoprevention of human prostate cancer by oral administration of green tea catechins 142
Influence of hyperbaric oxygen (HBO) on rat cardiac polyamine metabolism. 141
Apoptotic activity and levels of SGP-2 (clusterin) mRNA in the ventral prostate of the aging ra 141
A new transgenic model for prostate cancer (TRAMP/CluKO) and the role of CLU in tumorigenesis 141
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 140
EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism 138
Clusterin (CLU) and prostate cancer 136
Ca2+ depletion caused nuclear translocation of a 45kda death-isoform of clusterin and anoikis induction in prostate cells 134
Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kda nuclear isoform of clusterin 133
Clusterin (CLU) and lung cancer 133
Le catechine estratte dal tè verde per la prevenzione del tumore della prostata 133
Clusterin gene expression as a novel biomarker of response to chemoprevention with GTE in humans 129
N-Myc-mediated epigenetic reprogramming in advanced prostate cancer: personalized medicine and quality of biological samples 129
Clinical relevance of the inhibitory effect of Green Tea Catechins (GTCs) on prostate cancer progression in combination with molecular profiling of catechin-resistant tumors: an integrated view 129
Androgen responsiveness and intrarenal localization of transcripts coding for the enzymes of polyamine metabolism in the mouse 128
Determination of the level of expression of ODC, AdoMetDC, OAZ and SSAT for molecular classification of Green Tea Catechins-sensitive and –resistant Prostate Cancer in the TRAMP mice model by q-PCR gene profiling 127
Clusterin Mediated Apoptosis is Regulated by APC and is P21 Dependent but P53 Independent 126
Anti-tumor activity of polyphenols against prostate cancer 126
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread 122
Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas 122
The protective effect of Chrysanthemum fantanesii extract, vitamin E and C on sodium valproate-induced embryotoxicity in pregnant mice 121
Editorial: Challenges in the prevention of prostate cancer 120
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 119
Clusterin (SGP-2) gene expression is cell cycle dependent in normal human dermal fibroblasts 118
Clusterin is a short half-life, poly-ubiquitinated protein which controls the fate of prostate cancer cells 118
Clusterin is epigenetically repressed in human prostate cancer. 118
mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer 114
The tumor-suppressor activity of Clusterin (CLU) is fully displayed in a novel transgenic model for prostate cancer: the TRAMP/CluKO mice model 114
Clusterin (SGP-2) transient overexpression decreases proliferation rate of sv40-immortalised human prostate epithelial cells by slowing down cell cycle progression 114
Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5 years follow-up study 113
Development of a green fluorescent reporter for the bio-assay of anti-cancer drugs with anti-oxidant activity 111
Molecular mechanisms of the antimetastatic activity of nuclear clusterin in prostate cancer cells 111
Variazioni del profilo e della funzionalità polisomale di branzino (Dicentrarchus labrax) in condizioni di ridotto accrescimento 110
Human Prostate Cancer Prevention by Green Tea Catechins:Clinical Trial and Putative Molecular Mechanism of Action 110
Identification and characterization of a novel promoter of the CLU gene which drives the expression of a rare CLU mRNA variant in PCa cells following administration of epigenetic drugs. 110
Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts 109
Inhibitory Effects of Green Tea Catechins on Prostate Cancer progression 109
The Clusterin Paradigm in Prostate and Breast Carcinogenesis 108
Molecular classification of Green Tea Catechins-sensitive and -resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling 107
Increased levels of clusterin mRNA in the ventral prostate of the aging rat are associated to increases in cuboidal (atrophic) cell population and not to changes in apoptotic activity 107
Studies on the relationship between cell proliferation and cell death: apposite patterns of SGP-2 and ornithine decarboxylase mRNA accumulation in PHA-stimulated human limphocytes 107
Inhibition of spontaneous and androgen-induced prostate growth by a non hypercalcemic calcitriol analogue 106
Levels of SGP-2, ornithine decarboxylase (ODC) and glyceraldehyde phosphate dehydrogenase (GAPDH) mRNAs in several tissues of the aging rat 106
The new anti-oncogene clusterin and the molecular profiling of prostate cancer progression and prognosis 105
The Twin Sample™ (TS) needle: a novel device for prostate mapping which allows pathological analyses and molecular studies on the same tissue specimen 105
The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin overexpression 105
Totale 15.245
Categoria #
all - tutte 81.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 0 0 0 0 0 0 27
2021/20221.143 22 60 8 29 43 30 153 172 57 100 146 323
2022/20233.236 377 290 228 263 232 363 22 196 1.125 9 95 36
2023/20241.097 88 99 44 27 166 251 66 55 24 44 85 148
2024/20254.160 82 265 269 208 374 410 105 111 572 524 498 742
2025/20268.587 760 897 915 967 1.194 423 835 202 1.414 528 336 116
Totale 24.380